GlassScriptPhysician profile
Hitendra D Chauhan
NPI 1497757553
$1,318.99
in general payments reported to CMS, 2019-2025
17 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $46.35 · 2021: $20.34 · 2022: $117 · 2023: $302 · 2024: $327 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708 · Gift: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.67 |
| Gift | $184.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $393.61 | 2022-2025 | Mavyret, Rinvoq, Linzess |
| Janssen Pharmaceuticals, INC | $273.29 | 2019-2022 | |
| Braintree Laboratories, INC. | $263.80 | 2022-2024 | Suflave, Sutab |
| Cvrx, INC. | $111.86 | 2025 | Barostim Neo System |
| Sobi, INC | $54.68 | 2024 | |
| Merck Sharp & Dohme LLC | $27.61 | 2024 | Dificid |
| Exact Sciences Corporation | $25.45 | 2025 | Cologuard Collection Kit |
| Karyopharm Therapeutics INC. | $21.68 | 2023 | Xpovio |
| Janssen Biotech, INC. | $20.61 | 2025 | Tremfya |
| Astrazeneca Pharmaceuticals LP | $20.04 | 2023 | |
| Amgen INC. | $18.41 | 2023 | Lumakras |
| Takeda Pharmaceuticals U.S.A., INC. | $15.99 | 2023 | Gattex |
| Glaxosmithkline, LLC. | $15.88 | 2020 | |
| Boston Scientific Corporation | $15.51 | 2020 | |
| Radius Health, INC. | $14.96 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $14.14 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hitendra Chauhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.